Skip to content
Search

Latest Stories

DHSC issues multiple drug supply alerts

The Department of Health and Social Care (DHSC) has issued a supply disruption notification for Azathioprine tablets and updates regarding the ongoing shortages of Sayana Press injection, Mianserin, Disopyramide, Clonidine and Synphase tablets and Seroxat oral solution.

All suppliers of Azathioprine 25mg tablets are out of stock, according to the PSNC. This may last until the w/c January 27.


Pfizer’s contraceptive injection Sayana Press (medroxyprogesterone acetate 104mg), which is out of stock since August 2019 due to manufacturing delays, is now expected to be back for resupply in the first quarter of this year. Depo-Provera (medroxyprogesterone acetate 150 mg) is currently available to support the market if clinicians consider a medicine switch appropriate.

Mylan, which issued a supply notice for Mianserin 10 mg and 30mg tablets has now extended the resupply date to June 2020. The resupply date for the manufacturer’s Disopyramide 10 mg capsules also extended to March. However, supplies of both products are available from specialist importers.

The updated resupply date for Clonidine 25mcg tablets and Synphase (Ethinylestradiol and Norethisterone) tablets are also changed respectively to mid/end February 2020 and end January 2020.

DHSC also updated the resupply date for Seroxat (paroxetine) 20mg/10ml oral solution from previously announced January 2020 to February 2020 and reminded that paroxetine tablets, which can be prescribed in place of oral solutions, are available from various suppliers.

Unlicensed preparation of paroxetine 20mg/10ml oral solution is available from importers Clinigen, WEP Clinical, Mawdsleys and Target Healthcare Ltd.

If a prescriber wishes a pharmacist to dispense an import, PSNC advises to annotate such prescriptions as ‘specials/unlicensed’ in the prescribing line and endorse as follows:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

As per a memo from Specialist Pharmacy Service (SPS), the resupply date for Salofalk (mesalazine) suppositories 500mg by Dr Folk is also pushed back to mid-April 2020 with no date confirmed for the 1g suppositories.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less